The Glenmark drug recalls cover a wide range of commonly prescribed medicines — including ones that treat epilepsy, diabetes, multiple sclerosis, heart disease and high blood pressure.
Check the full list:
https://www.propublica.org/article/glenmark-recalls-two-dozen-drugs?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post
An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients
—
FDA inspectors found serious problems at a Glenmark factory in India that manufactured the recalled drugs. Another medication made there has been tied to deaths of U.S. patients.
https://www.propublica.org/article/glenmark-recalls-two-dozen-drugs?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post
"'We have a clinical definition of A.D.H.D. that is increasingly unanchored from what we’re finding in our science.' ... The preferred treatment for A.D.H.D. remains stimulant medications"
https://www.nytimes.com/2025/04/13/magazine/adhd-medication-treatment-research.html?unlocked_article_code=1._U4.TfKC.evgb_b6QSaQs&smid=nytcore-ios-share&referringSource=articleShare
Seigerman also pointed to concerns over recent #layoffs at the #FDA, saying the worries were now compounded by the "real talk" of #pharma #tariffs.
#Europe & the #US have interconnected supply chains for #medicines. The United States depends on medicines partly produced in Europe that bring in hundreds of billions of dollars in revenue.
"Given the complexity of the #pharma #SupplyChain, we do not expect the industry to make any major changes. These current tariffs are being pursued under emergency powers, which at worse will last until the end of the current administration & could end sooner with an act of #Congress."
Global #pharma shares plunge as #Trump doubles down on #tariff threat
Global drugmakers' #stocks dropped across the board after Trump reiterated plans for a "major" tariff on #pharmaceutical imports, threatening an interwoven global #SupplyChain, & as his country-specific reciprocal #tariffs took effect, leading to more pain in global markets.
#economy #inflation #recession #trumpcession #geopolitics
https://www.reuters.com/business/healthcare-pharmaceuticals/indian-pharma-stocks-decline-after-trump-again-threatens-tariffs-2025-04-09/
Update. New study: "#NIH investment in drugs approved from 2010 to 2019 was not less than investment by the #pharmaceutical industry, with comparable accounting for basic and applied research, failed clinical trials, and cost of capital or discount rates."
https://jamanetwork.com/journals/jama-health-forum/fullarticle/2804378
PS: Relevant to (1) #Trump admin cutbacks to NIH #funding and (2) industry #patents and licensing terms on approved drugs.
I just found out that my country has an agency that bargains with pharma and the healthcare industry to drive down prices
They also publish Plain English summaries (PES) of key drugs
Cool!
After years in Big Pharma, a chemist pivoted to help save the species that made weight-loss drugs possible.
#giftarticle #biodiversity #nature #ozempic #wegovy #pharma
Wenn wir unsere Bremsen nicht vom TÜV sondern von den Bremsenherstellern selbst kontrollieren lassen würden, wären höhere Ausgaben für Bremsen wahrscheinlich. Machen wir deshalb nicht.
Wenn bei der europäischen Leitlinie für Herzschrittmacher 88% dieser Autoren Gelder von im Schnitt fünf Herstellern eben dieser Geräte bekommen ... sind höhere Ausgaben für Herzschrittmacher zu erwarten. Sollten wir auch nicht machen!
Deshalb haben wir von #Leitlinienwatch diese europäische Leitlinie mit miesen 3/18 Punkten bewertet:
"China’s biotech boom mirrors its rise in tech. In both cases, China has moved up the value chain, from manufacturing goods to becoming a more sophisticated hub for innovation, competing in industries once dominated by the U.S. There are several reasons for the industry’s growth. For one, many top scientists trained in the U.S. have returned to China over the past decade, fueling the emergence of biotech hubs around Shanghai. And just as DeepSeek built a formidable chatbot—allegedly on a lean budget with limited access to semiconductors—Chinese biotech companies are also scrappier, capitalizing on a highly skilled, lower-cost workforce that can move faster.
Additionally, companies can conduct clinical trials at a fraction of what they would cost in the U.S., while recent changes in the Chinese regulatory system have streamlined and accelerated the approval process to get a study started.
For now, much of China’s biotech innovation is incremental rather than groundbreaking. Many companies focus on improving existing drugs—tweaking the chemistry, enhancing efficacy or differentiating them in key ways.
But Chinese innovation is steadily improving and is already starting to disrupt the U.S. drug-development ecosystem. For decades, the U.S. biotech industry has thrived in hubs such as Boston-Cambridge and the San Francisco Bay Area, fueled by talent streaming from top academic centers like Massachusetts Institute of Technology and Stanford University. Those biotech companies have an insatiable client in Big Pharma, which is willing to pay top dollar for new drugs to replace those going off-patent."
https://www.wsj.com/health/pharma/the-drug-industry-is-having-its-own-deepseek-moment-68589d70
@falcennial I learned that being the #Analyst #QuantJock for #CSuite #Corporate #Pharma #Biotech and #Government. There are two types at that level: (1) those who use #stats and #facts to #DefineReality, (2) those who use #stats and #facts to #PushTheirAgenda. #Trump and team are type (2)
My little science game released today! This is a small contribution to making what we do in pharma & biotech seem less foreign and more fun, in a time when making life-saving drugs is increasingly maligned in the public square.
Give it a download if you can - I appreciate the support :)
iOS:
https://apps.apple.com/us/app/research-rush/id6741133912
Android:
https://play.google.com/store/apps/details?id=com.TerraPrime.ResearchRush
My latest refill of PreP (anti-HIV Rx) perfectly demonstrates why medications are so grossly overpriced in the US.
The plain white bottle was an earlier refill and the fancy card fold-out with individual blister packed pills (I hate those) is the latest. The cost this uselessly-expensive and unnecessarily-complex packaging is about 10x that of the simple plastic bottle. It adds nothing.
Fuck you, Gilead Sciences, Inc. #Pharma
Here are 2 fundamental problems with the existing medical system;
1) the public directly fund the majority of medical research but outsource control of the studies, and ownership of the outputs;
https://www.tni.org/en/podcast/why-we-need-to-break-big-pharmas-power-before-the-next-pandemic-hits
2) companies selling medical products are allowed to conduct their own studies on safety and efficacy in private. So they can cherry-pick which ones to publish, based on what makes their products look good, and bury the rest.
(1/?)
Aktientip von mir ( hätte ich auch nicht gedacht das ich so etwas machen würde) #Pharma - Aktien gehen gerade runter, weil ein Impfkritiker und Schwurbler designierten Gesundheitsminister der USA ist. Ich sage kaufen. In ein paar Jahren machen die #Pharmaunternehmen in den USA richtig Geld mit der Behandlung chronischer Krankheitsfolgen für Krankheiten, die dank Impfung kein Thema gewesen wären. #Querdeppen #Schwurbler
https://www.europesays.com/1589952/ Hungary’s Várhelyi to face 2nd round of written questions – POLITICO #abortion #AnimalWelfare #HealthSystems #hír #hungary #Magyarország #Medicines #OliverVarhelyi #PatientRights #pharma #UrsulaVonDerLeyen #Women'sHealth
There's close to zero U.S. coverage of the global biodiversity summit happening now, where hundreds of people from around the world are fighting to save our planet's ability to sustain humanity. But the news is grim. https://www.ft.com/content/eece332f-a71e-4b7f-9a36-743aa041857f
#cop16 #biodiversity #uspol #climate #pharma
